Mustang Bio Inc. (NASDAQ:MBIO) shares, rose in value on Thursday, 05/12/22, with the stock price up by 3.16% to the previous day’s close as strong demand from buyers drove the stock to $0.66.
Actively observing the price movement in the last trading, the stock closed the session at $0.64, falling within a range of $0.6201 and $0.76. The value of beta (5-year monthly) was 1.60. Referring to stock’s 52-week performance, its high was $4.06, and the low was $0.62. On the whole, MBIO has fluctuated by -28.79% over the past month.
With the market capitalization of Mustang Bio Inc. currently standing at about $70.07 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 22, 2022 – Mar 28, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.19, which is expected to increase to -$0.18 for fiscal year -$0.73 and then to about -$0.76 by fiscal year 2022. Data indicates that the EPS growth is expected to be 36.00% in 2022, while the next year’s EPS growth is forecast to be -4.10%.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that MBIO’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of MBIO currently trading nearly -14.47% and -24.47% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 36.24, while the 7-day volatility ratio is showing 14.44% which for the 30-day chart, stands at 12.04%. Furthermore, Mustang Bio Inc. (MBIO)’s beta value is 1.76, and its average true range (ATR) is 0.09.
A comparison of Mustang Bio Inc. (MBIO) with its peers suggests the former has fared considerably weaker in the market. MBIO showed an intraday change of 3.16% in last session, and over the past year, it shrunk by -75.73%%. On the other hand, the price of Omeros Corporation (OMER) has risen 13.03% on the day. The stock, however, is off -83.91% from where it was a year ago. Other than that, the overall performance of the S&P 500 during the last trading session shows that it lost -0.13%. Meanwhile, the Dow Jones Industrial Slipped by -0.33%.
Data on historical trading for Mustang Bio Inc. (NASDAQ:MBIO) indicates that the trading volumes over the past 10 days have averaged 0.68 million and over the past 3 months, they’ve averaged 869.25K. According to company’s latest data on outstanding shares, there are 92.08 million shares outstanding.
Nearly 0.10% of Mustang Bio Inc.’s shares belong to company insiders and institutional investors own 28.20% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 2.62 million shares as on Dec 14, 2021, resulting in a short ratio of 2.14. According to the data, the short interest in Mustang Bio Inc. (MBIO) stood at 2.80% of shares outstanding as of Dec 14, 2021; the number of short shares registered in Nov 14, 2021 reached 2.83 million. The stock has fallen by -60.53% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MBIO stock heading into the next quarter.